Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Indian J Public Health ; 67(3): 463-467, 2023.
Article in English | MEDLINE | ID: mdl-37929392

ABSTRACT

Severe acute malnutrition (SAM) is a major public health concern in Yemen, particularly in areas affected by ongoing conflict war. SAM is defined as a very low weight for height, by visible severe wasting, or by the presence of nutritional edema. The prevalence of SAM in Yemen has increased dramatically since the onset of the conflict. Prior studies have focused on evaluating prevalence, but this novel study aimed to assess the risk factors associated with SAM prevalence. Five thousand two hundred and seventeen patients of SAM admitted at 12 sentinel hospitals were enrolled, and data were collected and analyzed. Marasmus was the most common form. Numerous risk factors contribute to the high prevalence of SAM in Yemen, including food insecurity. The current conflict has hampered food production, distribution, and access. Awareness of risk factors can prevent SAM in the general population.


Subject(s)
Malnutrition , Severe Acute Malnutrition , Humans , Child , Infant , Yemen/epidemiology , India , Severe Acute Malnutrition/epidemiology , Risk Factors , Thinness , Malnutrition/epidemiology
2.
Int J Epidemiol ; 52(4): 1175-1186, 2023 08 02.
Article in English | MEDLINE | ID: mdl-37128839

ABSTRACT

BACKGROUND: Acute bacterial meningitis (ABM) is a serious health issue in Yemen where civil war, which continues unabated, has crippled the healthcare system. We conducted a nationwide retrospective observational study in Yemeni sentinel hospitals to identify the prevalence, aetiology, vaccination coverage and spatio-temporal pattern of ABM in children aged <5 years before and during the civil war, 2014-20. METHODS: Cerebrospinal fluid samples were collected from hospitalized children and were analysed macroscopically for appearance and microscopically by Gram stain and white blood cell count. Culture and latex agglutination tests were performed. Data on the prevalence of and vaccination coverage for ABM were obtained from the Ministry of Health. Joinpoint regression was used to assess the annual percent change (APC) of ABM prevalence and vaccination coverage. Pearson's correlation was used to evaluate the association between ABM prevalence and vaccination coverage. RESULTS: In total, 11 339 hospitalized children had suspected cases of ABM (prevalence, 40.07/100 000 of the whole Yemeni population) and 2.6% (293/11 339) of suspected ABM cases were confirmed (prevalence, 1.04/100 000 of the whole Yemeni population). The dominant pathogens were Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae type b (Hib). The civil war reduced the Hib and pneumococcal vaccination coverage (APC = -1.92), reaching its lowest (79.5%) in 2018. The prevalence of suspected ABM increased (APC = 3.46), reaching its maximum (6.08/100 000 of the whole Yemeni population) in 2019. The conflict inversely correlated with the ABM prevalence and vaccination coverage (Pearson correlation coefficient (r), -0.69 to -0.53). Ta'izz region, which was severely affected by the civil war, had the highest prevalence of suspected ABM (120.90/100 000 of the whole Yemeni population) and lowest vaccination coverage (60%). CONCLUSIONS: The civil war had a negative impact on vaccination coverage and coincided with increasing prevalence of ABM in Yemen. Streptococcus pneumoniae is the dominant causative pathogen.


Subject(s)
Haemophilus influenzae type b , Meningitis, Bacterial , Child , Humans , Infant , Prevalence , Yemen/epidemiology , Vaccination Coverage , Meningitis, Bacterial/epidemiology , Meningitis, Bacterial/prevention & control , Meningitis, Bacterial/microbiology , Streptococcus pneumoniae , Hospitals
3.
Cell Mol Biol Lett ; 27(1): 69, 2022 Aug 19.
Article in English | MEDLINE | ID: mdl-35986247

ABSTRACT

Human mesenchymal stem cells (MSCs) are primary multipotent cells capable of differentiating into osteocytes, chondrocytes, and adipocytes when stimulated under appropriate conditions. The role of MSCs in tissue homeostasis, aging-related diseases, and cellular therapy is clinically suggested. As aging is a universal problem that has large socioeconomic effects, an improved understanding of the concepts of aging can direct public policies that reduce its adverse impacts on the healthcare system and humanity. Several studies of aging have been carried out over several years to understand the phenomenon and different factors affecting human aging. A reduced ability of adult stem cell populations to reproduce and regenerate is one of the main  contributors to the human aging process. In this context, MSCs senescence is a major challenge in front of cellular therapy advancement. Many factors, ranging from genetic and metabolic pathways to extrinsic factors through various cellular signaling pathways, are involved in regulating the mechanism of MSC senescence. To better understand and reverse cellular senescence, this review highlights the underlying mechanisms and signs of MSC cellular senescence, and discusses the strategies to combat aging and cellular senescence.


Subject(s)
Mesenchymal Stem Cells , Adult , Aging/metabolism , Biomarkers/metabolism , Cell Differentiation , Cells, Cultured , Cellular Senescence/genetics , Humans , Mesenchymal Stem Cells/metabolism , Multipotent Stem Cells/metabolism
4.
Clin Lab ; 67(8)2021 Aug 01.
Article in English | MEDLINE | ID: mdl-34383409

ABSTRACT

BACKGROUND: Pseudomonas aeruginosa is a Gram-negative bacteria that causes a large range of human infections such as lung infection (cystic fibrosis) and urinary tract infection. Even worse, antibiotic resistant bacteria have become a serious health care problem throughout the last decade, and there is a need for a clear approach to regulate and prevent the spread of pseudomonas aeruginosa resistance. METHODS: A complete analysis of Pseudomonas aeruginosa proteomics data showed that 25% of proteins are hypothetical proteins (HPs) whose function is not precisely defined. HP gene sequence analysis offers a framework for defining sequence-function relationships with a deeper understanding of organisms' molecular mechanisms at the system level. In the current research, we used the power of different bioinformatics tools to assign the potential roles for the HPs based on protein family association, amino acid function, motifs, and pathway analysis. RESULTS: The current findings show that 30 HPs have well-defined functions and are classified as enzymes, DNA binding, periplasmic binding protein, transport, etc. Seven HPs showed virulence characteristics that is to be expected to be essential for Pseudomonas aeruginosa and pathogenesis survival. CONCLUSIONS: This study's findings may encourage a better understanding of virulence mechanisms, drug resistance, pathogenesis, and drug discovery to treat Pseudomonas aeruginosa infections.


Subject(s)
Cystic Fibrosis , Pseudomonas Infections , Anti-Bacterial Agents/pharmacology , Drug Resistance, Microbial , Humans , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/genetics , Virulence
5.
Brain Behav ; 11(8): e2280, 2021 08.
Article in English | MEDLINE | ID: mdl-34291612

ABSTRACT

Recently, genome-editing technology like clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 has improved the translational gap in the treatments mediated through gene therapy. The advantages of the CRISPR system, such as, work in the living cells and tissues, candidate this technique for the employing in experiments and the therapy of central nervous system diseases. Parkinson's disease (PD) is a widespread, disabling, neurodegenerative disease induced by dopaminergic neuron loss and linked to progressive motor impairment. Pathophysiological basis knowledge of PD has modified the PD classification model and expresses in the sporadic and familial types. Analyses of the earliest genetic linkage have shown in PD the inclusion of synuclein alpha (SNCA) genomic duplication and SNCA mutations in the familial types of PD pathogenesis. This review analyzes the structure, development, and function in genome editing regulated through the CRISPR/Cas9. Also, it explains the genes associated with PD pathogenesis and the appropriate modifications to favor PD. This study follows the direction by understanding the PD linking analyses in which the CRISPR technique is applied. Finally, this study explains the limitations and future trends of CRISPR service in relation to the genome-editing process in PD patients' induced pluripotent stem cells.


Subject(s)
Neurodegenerative Diseases , Parkinson Disease , CRISPR-Cas Systems/genetics , Gene Editing , Humans , Parkinson Disease/genetics , Parkinson Disease/therapy , alpha-Synuclein
6.
J Virol ; 95(15): e0056321, 2021 07 12.
Article in English | MEDLINE | ID: mdl-34011546

ABSTRACT

Human respiratory syncytial virus (hRSV) is the most common pathogen which causes acute lower respiratory infection (ALRI) in infants. Recently, virus-host interaction has become a hot spot of virus-related research, and it needs to be further elaborated for RSV infection. In this study, we found that RSV infection significantly increased the expression of cyclophilin A (cypA) in clinical patients, mice, and epithelial cells. Therefore, we evaluated the function of cypA in RSV replication and demonstrated that virus proliferation was accelerated in cypA knockdown host cells but restrained in cypA-overexpressing host cells. Furthermore, we proved that cypA limited RSV replication depending on its PPIase activity. Moreover, we performed liquid chromatography-mass spectrometry, and the results showed that cypA could interact with several viral proteins, such as RSV-N, RSV-P, and RSV-M2-1. Finally, the interaction between cypA and RSV-N was certified by coimmunoprecipitation and immunofluorescence. Those results provided strong evidence that cypA may play an inhibitory role in RSV replication through interaction with RSV-N via its PPIase activity. IMPORTANCE RSV-N, packed in the viral genome to form the ribonucleoprotein (RNP) complex, which is recognized by the RSV RNA-dependent RNA polymerase (RdRp) complex to initiate viral replication and transcription, plays an indispensable role in the viral biosynthesis process. cypA, binding to RSV-N, may impair this function by weakening the interaction between RSV-N and RSV-P, thus leading to decreased viral production. Our research provides novel insight into cypA antiviral function, including binding to viral capsid protein to inhibit viral replication, which may be helpful for new antiviral drug exploration.


Subject(s)
Cyclophilin A/genetics , Cyclophilin A/metabolism , Peptidylprolyl Isomerase/metabolism , Respiratory Syncytial Virus, Human/growth & development , Virus Replication/physiology , Animals , Cell Line , Chlorocebus aethiops , Female , Humans , Mass Spectrometry , Mice , Mice, Inbred BALB C , RNA Interference , RNA, Small Interfering/genetics , Respiratory Syncytial Virus Infections/pathology , Ribonucleoproteins/metabolism , Vero Cells , Viral Nonstructural Proteins/metabolism , Viral Proteins/metabolism
7.
Int Immunopharmacol ; 89(Pt B): 107023, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33129098

ABSTRACT

Liver disease is a global health problem and is a primary cause of mortality and morbidity worldwide. Specifically, it accounts for approximately two million deaths per year worldwide. The common causes of mortality are the complications of liver cirrhosis, viral hepatitis and hepatocellular carcinoma (HCC). The mechanism of immune response and infiltration of cellular immunity is essential for promoting hepatic inflammatory, especially when the liver is abundant with lymphocytes and phagocytic cells. The injured and immunity cells secret different types of interleukins (cytokines), which can directly or indirectly amplify or inhibit liver inflammation. Many types of cells can produce interleukin-34 (IL-34) that induces the release of multiple inflammatory factors in patients via interaction with various cytokines. This phenomenon leads to the enlargement of the inflammatory response to liver diseases and induces liver fibrosis. This review highlights the proposed roles of IL-34 in liver diseases and discusses the recent findings of IL-34 that support its emerging role in HCC. Specifically, the facilitating effects of these new insights on the rational development of IL-34 for targeted therapies in the future are explored.


Subject(s)
Inflammation Mediators/metabolism , Interleukins/metabolism , Liver Diseases/metabolism , Liver/metabolism , Animals , Anti-Inflammatory Agents/therapeutic use , Gene Expression Regulation , Humans , Interleukins/genetics , Liver/drug effects , Liver/immunology , Liver/pathology , Liver Diseases/drug therapy , Liver Diseases/genetics , Liver Diseases/immunology , Signal Transduction
8.
Biomed Pharmacother ; 131: 110594, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32858499

ABSTRACT

Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) and the active metabolite is rhein. It is a non-steroidal anti-inflammatory drug with unique pharmacological properties as anti-oxidant and anti-apoptosis. Diacerein has recently shown to have a potential role by mediating anti-inflammatory as well as anti-oxidant and anti-apoptosis in kidney injury, diabetes mullites, and a beneficial effect on pain relief. It may have a therapeutic role in cancer, ulcerative colitis, testicular injury and cervical hyperkeratosis. Furthermore, diacerein has a valuable addition in combination therapy as a synergetic agent. This review, the first of its kind, highlights the proposed roles of diacerein in osteoarthritis and discusses recent results supporting its emerging roles with a particular focus on how these new insights may facilitate the rational development of diacerein for targeted therapies in the future.


Subject(s)
Anthraquinones/pharmacology , Anti-Inflammatory Agents/pharmacology , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/metabolism , Signal Transduction/drug effects , Animals , Anthraquinones/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Diabetes Mellitus/drug therapy , Diabetes Mellitus/metabolism , Gastrointestinal Diseases/drug therapy , Gastrointestinal Diseases/metabolism , Humans , Kidney Diseases/drug therapy , Kidney Diseases/metabolism , Osteoarthritis/drug therapy , Osteoarthritis/metabolism , Signal Transduction/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...